Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Federico Simonetta, MD PhD, Hélène Labussière-Wallet, MD, Maciej J Machaczka, MD, Flore Sicre de Fontbrune, MD, Michael Medinger, MD, Sylvain Chantepie, MD, Tony Marchand, MD, Stavroula Masouridi-Levrat, MD, Marie-Thérèse Rubio, MD PhD, Oumedaly Reman, MD, Nathalie Dhedin, MD, Loic Fouillard, MD, Olivier Lambotte, MD PhD, Lionel Galicier, MD, Paul Coppo, MD PhD, Jakob Passweg, MD, Ibrahim Yakoub-Agha, MD PhD, Regis Peffault De Latour, MD PhD, Yves Chalandon, MD

Blood (2016) 128 (22): 4617.

https://doi.org/10.1182/blood.V128.22.4617.4617

Published: 2016

Journal Articles

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

Hartmut Döhner, Michael Lübbert, Walter Fiedler, Loic Fouillard, Alf Haaland, Joseph M. Brandwein, Stephane Lepretre, Oumedaly Reman, Pascal Turlure, Oliver G. Ottmann, Carsten Müller-Tidow, Alwin Krämer, Emmanuel Raffoux, Konstanze Döhner, Richard F. Schlenk, Florian Voss, Tillmann Taube, Holger Fritsch, Johan Maertens

Blood (2014) 124 (9): 1426–1433.

https://doi.org/10.1182/blood-2014-03-560557

Published: 2014

Includes: Supplemental data

Journal Articles

Phase I/II Study of Volasertib (BI 6727), an Intravenous Polo-Like Kinase (Plk) Inhibitor, in Patients with Acute Myeloid Leukemia (AML): Results From the Randomized Phase II Part for Volasertib in Combination with Low-Dose Cytarabine (LDAC) Versus LDAC Monotherapy in Patients with Previously Untreated AML Ineligible for Intensive Treatment

Johan Maertens, MD, PhD, Michael Lübbert, MD, Walter Fiedler, MD, Loic Fouillard, Alf Haaland, MD, Joseph M. Brandwein, MD, Stéphane Lepretre, MD, Oumédaly Reman, MD, Pascal Turlure, MD, Gesine Bug, Carsten Müller-Tidow, Alwin Krämer, MD, Florian Voss, PhD, Tillmann Taube, MD, Holger Fritsch, PhD, Hartmut Döhner, MD

Blood (2012) 120 (21): 411.

https://doi.org/10.1182/blood.V120.21.411.411

Published: 2012

Journal Articles

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Blood (2010) 116 (21): 2359.

https://doi.org/10.1182/blood.V116.21.2359.2359

Published: 2010

Journal Articles

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

Karin Tarte, Julien Gaillard, Jean-Jacques Lataillade, Loic Fouillard, Martine Becker, Hossein Mossafa, Andrei Tchirkov, Hélène Rouard, Catherine Henry, Marie Splingard, Joelle Dulong, Delphine Monnier, Patrick Gourmelon, Norbert-Claude Gorin, Luc Sensebé, on behalf of Société Française de Greffe de Moelle et Thérapie Cellulaire

Blood (2010) 115 (8): 1549–1553.

https://doi.org/10.1182/blood-2009-05-219907

Published: 2010

Includes: Supplemental data

Journal Articles

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Blood (2009) 114 (22): 4335.

https://doi.org/10.1182/blood.V114.22.4335.4335

Published: 2009

Journal Articles

Double Cord Blood Cell (CBC) Hematopoietic Stem Cell Transplantation after Standard or Reduced Intensity Conditioning: Report of the SFGMTC Registry.

Blood (2008) 112 (11): 1972.

https://doi.org/10.1182/blood.V112.11.1972.1972

Published: 2008

Journal Articles

Human Mesenchymal Stem Cells Express HLA-G: Role in MSC Mediated Immunosuppressive Effect.

Alain Chapel, PhD, Aisha Nasef, MD, Noelle Mathieu, MD, Johanna Frick, tec, Sandrine Bouchet, tec, Norbert C. Gorin, Dominique Thierry, PhD, Loic Fouillard, MD, PhD

Blood (2006) 108 (11): 4257.

https://doi.org/10.1182/blood.V108.11.4257.4257

Published: 2006

Journal Articles

Allogeneic Related HLA Mismatch Mesenchymal Stem Cells for the Treatment of Engraftment Failure Following Autologous Hematopoietic Stem Cell Transplantation.

Loic Fouillard, MD, PhD, Alain Chapel, PhD, Domnique Bories, MD, PhD, Sandrine Bouchet Tec, Helene Rouard, PhD, Patrick Herve, Patrick Gourmelon, MD, Dominique Thierry, MD, PhD, Norbert C. Gorin

Blood (2006) 108 (11): 2560.

https://doi.org/10.1182/blood.V108.11.2560.2560

Published: 2006

Journal Articles

Allogeneic Myelo-Ablative Stem Cell Transplant (SCT) as Salvage Therapy of Reduced-Intensity Conditioned (RIC) SCT: Toxicity and Outcome.

Catherine Cordonnier, MD, Rose-marie Hamladji, MD, Alois Gratwohl, MD, Per Ljungman, MD, Rodrigo Martino, MD, Pierre Bordigoni, MD, Sylvie François, MD, Eric Deconninck, MD, Agnes Buzyn, MD, Jacques-Olivier Bay, MD, Loic Fouillard, MD, Mathieu Kuentz, MD

Blood (2005) 106 (11): 3666.

https://doi.org/10.1182/blood.V106.11.3666.3666

Published: 2005

Journal Articles

Stro-1 Positive and Stro-1 Negative Human Mesenchymal Stem Cells Express Different Levels of Immunosuppression.

Sabine Francois, Yizhuo Zhang, MD, Morad Bensidhoum, PhD, Christelle Mazurier, Aisha Nasef, MD, Sandrine Bouchet, Noelle Mathieu, PhD, Norbert-Claude Gorin, MD, Manuel Lopez, PhD, Michel Bourgeade, MD, Dominique Thierry, PhD, Alain Chapel, PhD, Loic Fouillard, MD

Blood (2005) 106 (11): 2305.

https://doi.org/10.1182/blood.V106.11.2305.2305

Published: 2005

Journal Articles

Syngeneic Hematopoietic Stem Cell Transplantation in Acute Leukaemia. A Report of the Acute Leukaemia Working Party of the EBMT.

Loic Fouillard, MD, Myriam Labopin, MD, Eliane Gluckman, Alois Gratwohl, Francesco Frassoni, MD, Norbert Claude Gorin, Vanderson Rocha, MD

Blood (2004) 104 (11): 2303.

https://doi.org/10.1182/blood.V104.11.2303.2303

Published: 2004

Journal Articles

Retrospective Comparison of Using or Not Using Donor Lymphocyte Transfusion in the Treatment of Hematological Relapse after Allogeneic Stem Cell Transplantation in 489 Adults with Acute Myeloid Leukemia.

Christoph Schmid, MD, Myriam Labopin, MD, Juergen Finke, MD, Gerhard Ehninger, MD, Olle Ringden, MD, Dietger Niederwieser, MD, Ioanna Sakellari, MD, Alvaro Urbano-Ispizua, MD, Tapani Ruutu, MD, Gunham Gurman, MD, Richard E. Clarke, MD, Norbert Gorin, MD, Emmanuelle Polge, Loic Fouillard, MD, Francesco Frassoni, MD, Hans-Jochem Kolb, MD, Vanderson Rocha for the EMBT ALWP

Blood (2004) 104 (11): 298.

https://doi.org/10.1182/blood.V104.11.298.298

Published: 2004

Journal Articles

Inhibition of T Lymphocyte (TL) Proliferation by Mesenchymal Stem Cells (MSCs): Role of Cell Contact between MSCs and TL, Role of MSCs Dose Effect, and Role of Soluble Factors and Adhesion Molecules Expressed by MSCs.

Aisha Nasef, MD, Alain Chapel, PhD, Morad Benshidom, PhD, Yizhuo Zang, MD, Christelle Mazurier, Sandrine Bouchet, Manuel Lopez, PhD, Norbert Claude Gorin, Pr, Dominique Thierry, PhD, Loic Fouillard, MD, PhD

Blood (2004) 104 (11): 4251.

https://doi.org/10.1182/blood.V104.11.4251.4251

Published: 2004

Journal Articles

In Vitro Purging in Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukaemia. A Retrospective Analysis on Behalf of the Chronic Leukaemia Working Party of the EBMT.

Loic Fouillard, MD, PhD, Mauricette Michallet, Anja Van-biezen, D.W. Miligan, MD, Paolo Corradini, MD, Norbert Claude Gorin, Dietger Niederwieser

Blood (2004) 104 (11): 148.

https://doi.org/10.1182/blood.V104.11.148.148

Published: 2004

Journal Articles

Homing of in vitro expanded Stro-1 - or Stro-1 + human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment

Morad Bensidhoum, Alain Chapel, Sabine Francois, Christelle Demarquay, Christelle Mazurier, Loic Fouillard, Sandrine Bouchet, Jean Marc Bertho, Patrick Gourmelon, Jocelyne Aigueperse, Pierre Charbord, Norbert Claude Gorin, Dominique Thierry, Manuel Lopez

Blood (2004) 103 (9): 3313–3319.

https://doi.org/10.1182/blood-2003-04-1121

Published: 2004

NARROW

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Double Cord Blood Cell (CBC) Hematopoietic Stem Cell Transplantation after Standard or Reduced Intensity Conditioning: Report of the SFGMTC Registry.

Human Mesenchymal Stem Cells Express HLA-G: Role in MSC Mediated Immunosuppressive Effect.

Allogeneic Related HLA Mismatch Mesenchymal Stem Cells for the Treatment of Engraftment Failure Following Autologous Hematopoietic Stem Cell Transplantation.

Allogeneic Myelo-Ablative Stem Cell Transplant (SCT) as Salvage Therapy of Reduced-Intensity Conditioned (RIC) SCT: Toxicity and Outcome.

Stro-1 Positive and Stro-1 Negative Human Mesenchymal Stem Cells Express Different Levels of Immunosuppression.

Syngeneic Hematopoietic Stem Cell Transplantation in Acute Leukaemia. A Report of the Acute Leukaemia Working Party of the EBMT.

Retrospective Comparison of Using or Not Using Donor Lymphocyte Transfusion in the Treatment of Hematological Relapse after Allogeneic Stem Cell Transplantation in 489 Adults with Acute Myeloid Leukemia.

Inhibition of T Lymphocyte (TL) Proliferation by Mesenchymal Stem Cells (MSCs): Role of Cell Contact between MSCs and TL, Role of MSCs Dose Effect, and Role of Soluble Factors and Adhesion Molecules Expressed by MSCs.

In Vitro Purging in Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukaemia. A Retrospective Analysis on Behalf of the Chronic Leukaemia Working Party of the EBMT.

Homing of in vitro expanded Stro-1 - or Stro-1 + human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only